On- and off-target effects of paired CRISPR-Cas nickase in primary human cells

Julia Klermund1, Manuel Rhiel1, Thomas Kocher2

  • 1Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg, 79106 Freiburg, Germany; Center for Chronic Immunodeficiency (CCI), Medical Center - University of Freiburg, 79106 Freiburg, Germany.

Insights

Double-nickase CRISPR strategies offer efficient genome editing with fewer off-target mutations. However, this approach can still cause significant chromosomal aberrations at on-target sites, impacting genome integrity.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • CRISPR-Cas9 nucleases face challenges with on- and off-target effects.
  • Cas9 nickases reduce off-target mutations but lack therapeutic efficacy.
  • Double-nickase strategies aim for high-efficiency gene editing via staggered DNA breaks.

Purpose of the Study:

  • To investigate chromosomal aberrations induced by paired CRISPR-Cas9 nickases.
  • To evaluate the impact of double-nickase editing on genome integrity.
  • To compare on-target aberrations from nucleases versus double-nickases.

Main Methods:

  • Developed and utilized a novel CAST-seq pipeline, dual CAST.
  • Characterized chromosomal aberrations at three loci (COL7A1, COL17A1, LAMA3) in patient-derived keratinocytes.
  • Compared aberrations induced by Cas9 nucleases and paired Cas9 nickases.

Main Results:

  • Cas9 nucleases induced chromosomal rearrangements, but no translocations were observed with paired nickases.
  • Double-nickase editing resulted in large deletions/inversions near target sites.
  • On-target aberrations from double-nickases included a high proportion of insertions, differing qualitatively from nuclease-induced aberrations.

Conclusions:

  • Double-nickase CRISPR approaches provide efficient editing with reduced off-target effects.
  • Significant chromosomal aberrations persist at on-target sites even with double-nickase strategies.
  • Further research is needed to fully understand and mitigate on-target effects of double-nickase genome editing.